Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M van Weerden

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
The American Journal of Pathology|February 23, 1999
Kinetics of neuroendocrine differentiation in an androgen-dependent human prostate xenograft modelJ Jongsma, M H Oomen, M A Noordzij, et al.
Human Gene Therapy|June 8, 2011
Disconnecting the yin and yang relation of epidermal growth factor receptor (EGFR)-mediated delivery: a fully synthetic, EGFR-targeted gene transfer system avoiding receptor activationA Schäfer, A Pahnke, D Schaffert, et al.
International Journal of Cancer|October 3, 1999
Identification of a gene on human chromosome 8q11 that is differentially expressed during prostate-cancer progressionG T Chang, N Tapsi, M Steenbeek, et al.
Journal of the National Cancer Institute|September 7, 2000
Characterization of a zinc-finger protein and its association with apoptosis in prostate cancer cellsG T Chang, M Steenbeek, E Schippers, et al.
European Journal of Cancer (Oxford, England : 1990)|October 13, 2001
A novel gene on human chromosome 2p24 is differentially expressed between androgen-dependent and androgen-independent prostate cancer cellsG T Chang, M Steenbeek, E Schippers, et al.
The Journal of Pathology|May 16, 2007
Overexpression and gene amplification of BAG-1L in hormone-refractory prostate cancerH E Mäki, O R Saramäki, L Shatkina, et al.
British Journal of Cancer|January 19, 2000
Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissuesR H van Schaik, C D Wierikx, M A Timmerman, et al.
Oncogene|September 20, 2017
Endogenous androgen receptor proteomic profiling reveals genomic subcomplex involved in prostate tumorigenesisS Stelloo, E Nevedomskaya, Y Kim, et al.
EJNMMI Research|January 16, 2016
Imaging heterogeneity of peptide delivery and binding in solid tumors using SPECT imaging and MRIJ C Haeck, K Bol, C M A de Ridder, et al.
European Journal of Cancer (Oxford, England : 1990)|November 9, 2013
Cross-resistance between taxanes and new hormonal agents abiraterone and enzalutamide may affect drug sequence choices in metastatic castration-resistant prostate cancerR J van Soest, M E van Royen, E S de Morrée, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The American Journal of Pathology|February 23, 1999
Kinetics of neuroendocrine differentiation in an androgen-dependent human prostate xenograft modelJ Jongsma, M H Oomen, M A Noordzij, et al.
Human Gene Therapy|June 8, 2011
Disconnecting the yin and yang relation of epidermal growth factor receptor (EGFR)-mediated delivery: a fully synthetic, EGFR-targeted gene transfer system avoiding receptor activationA Schäfer, A Pahnke, D Schaffert, et al.
International Journal of Cancer|October 3, 1999
Identification of a gene on human chromosome 8q11 that is differentially expressed during prostate-cancer progressionG T Chang, N Tapsi, M Steenbeek, et al.
Journal of the National Cancer Institute|September 7, 2000
Characterization of a zinc-finger protein and its association with apoptosis in prostate cancer cellsG T Chang, M Steenbeek, E Schippers, et al.
European Journal of Cancer (Oxford, England : 1990)|October 13, 2001
A novel gene on human chromosome 2p24 is differentially expressed between androgen-dependent and androgen-independent prostate cancer cellsG T Chang, M Steenbeek, E Schippers, et al.
The Journal of Pathology|May 16, 2007
Overexpression and gene amplification of BAG-1L in hormone-refractory prostate cancerH E Mäki, O R Saramäki, L Shatkina, et al.
British Journal of Cancer|January 19, 2000
Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissuesR H van Schaik, C D Wierikx, M A Timmerman, et al.
Oncogene|September 20, 2017
Endogenous androgen receptor proteomic profiling reveals genomic subcomplex involved in prostate tumorigenesisS Stelloo, E Nevedomskaya, Y Kim, et al.
EJNMMI Research|January 16, 2016
Imaging heterogeneity of peptide delivery and binding in solid tumors using SPECT imaging and MRIJ C Haeck, K Bol, C M A de Ridder, et al.
European Journal of Cancer (Oxford, England : 1990)|November 9, 2013
Cross-resistance between taxanes and new hormonal agents abiraterone and enzalutamide may affect drug sequence choices in metastatic castration-resistant prostate cancerR J van Soest, M E van Royen, E S de Morrée, et al.
Pageof 4